— Know what they know.
Not Investment Advice

RTGN OTC

RetinalGenix Technologies Inc.
1W: +0.0% 1M: -0.2% 3M: -0.2% YTD: +24.7% 1Y: +12.7% 3Y: -44.2%
$3.99
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 43 · $75.2M mcap · 6M float · 0.0001% daily turnover · Short 97% of daily vol

Cash Flow Trends

Operating Cash Flow
-$742K -113.0% ▼
Capital Expenditures
$4 +0.0% ▲
Free Cash Flow
-$742K -113.0% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$6K +16047.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$2M-$2M-$4M-$2M-$4M
Depreciation & Amort.$0$0$51$100$954
Stock-Based Comp.$220K$308K$259K$664K$3M
Change in Working Capital$92K$156K$230K$4K$189K
Other Non-Cash Items$343K$548K$3M$1M$779K
Operating Cash Flow-$1M-$1M-$199K-$348K-$742K
— Investing Activities —
Capital Expenditures$0$0-$307$0$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow$0$0-$307$0$0
— Financing Activities —
Net Debt Issuance$0$73K$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$25K$14K$134K$348K$245K
Financing Cash Flow$1M$1M$195K$348K$748K
Net Change in Cash-$52K$3K-$5K-$38$6K
Cash End of Period$2K$5K$38$0$6K
Free Cash Flow-$1M-$1M-$200K-$348K-$742K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms